SCHEMBL4044939

SCHEMBL4044939

CCc1ccc(C2(C(C(=O)NC3CCCCC3)C3CCCCC3)Nc3ccccc3N2)cc1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.44
MAPT P10636 1/20 0.43
KMT2A Q03164 3/20 0.43
MEN1 O00255 2/20 0.41
POLB P06746 1/20 0.41
TSHR P16473 2/20 0.41
MMP1 P03956 1/20 0.40
ALDH1A1 P00352 2/20 0.40
EPHX1 P07099 1/20 0.40
HPGD P15428 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
TP53 P04637 1/20 0.40
EPHX2 P34913 1/20 0.40
KDM4E B2RXH2 1/20 0.39
HTT P42858 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4755424 0.90 SMN1; SMN2 (0.42) NPC1RAB9ASMN1; SMN2MAPTKMT2A
SCHEMBL4041915 0.90 SMN1; SMN2 (0.42) NPC1RAB9ASMN1; SMN2MAPTKMT2A
SCHEMBL4042940 0.87 TSHR (0.45) NPC1RAB9ASMN1; SMN2KMT2AMEN1
SCHEMBL4037901 0.86 POLB (0.40) RAB9ASMN1; SMN2MAPTKMT2AMEN1
SCHEMBL4040671 0.86 NPC1 (0.45) NPC1RAB9ASMN1; SMN2MAPTKMT2A
SCHEMBL4041199 0.86 SMN1; SMN2 (0.47) NPC1RAB9ASMN1; SMN2KMT2AMEN1
SCHEMBL4042732 0.85 NR1H4 (0.44) NPC1RAB9ASMN1; SMN2MAPTKMT2A
SCHEMBL4040005 0.85 KMT2A (0.43) NPC1RAB9ASMN1; SMN2KMT2AMEN1
SCHEMBL4039101 0.85 NR1H4 (0.44) NPC1RAB9ASMN1; SMN2MAPTKMT2A
SCHEMBL4037453 0.85 EPHX1 (0.43) NPC1RAB9ASMN1; SMN2MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2038259-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP disclosed
WO-2008000643-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO disclosed